<?xml version='1.0' encoding='utf-8'?>
<document id="22694788"><sentence text="Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp." /><sentence text="We evaluated isothermal microcalorimetry for real-time susceptibility testing of non-Aspergillus molds" /><sentence text=" MIC and minimal effective concentration (MEC) values of Mucorales (n = 4), Fusarium spp" /><sentence text=" (n = 4), and Scedosporium spp" /><sentence text=" (n = 4) were determined by microbroth dilution according to the Clinical Laboratory Standard Institute M38-A2 guidelines" /><sentence text=" Heat production of molds was measured at 37 °C in Sabouraud dextrose broth inoculated with 2" /><sentence text="5 × 10(4) spores/mL in the presence of amphotericin B, voriconazole, posaconazole, caspofungin, and anidulafungin"><entity charOffset="39-53" id="DDI-PubMed.22694788.s7.e0" text="amphotericin B" /><entity charOffset="55-67" id="DDI-PubMed.22694788.s7.e1" text="voriconazole" /><entity charOffset="69-81" id="DDI-PubMed.22694788.s7.e2" text="posaconazole" /><entity charOffset="83-94" id="DDI-PubMed.22694788.s7.e3" text="caspofungin" /><entity charOffset="100-113" id="DDI-PubMed.22694788.s7.e4" text="anidulafungin" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e0" e2="DDI-PubMed.22694788.s7.e0" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e0" e2="DDI-PubMed.22694788.s7.e1" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e0" e2="DDI-PubMed.22694788.s7.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e0" e2="DDI-PubMed.22694788.s7.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e0" e2="DDI-PubMed.22694788.s7.e4" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e1" e2="DDI-PubMed.22694788.s7.e1" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e1" e2="DDI-PubMed.22694788.s7.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e1" e2="DDI-PubMed.22694788.s7.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e1" e2="DDI-PubMed.22694788.s7.e4" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e2" e2="DDI-PubMed.22694788.s7.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e2" e2="DDI-PubMed.22694788.s7.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e2" e2="DDI-PubMed.22694788.s7.e4" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e3" e2="DDI-PubMed.22694788.s7.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s7.e3" e2="DDI-PubMed.22694788.s7.e4" /></sentence><sentence text=" As determined by microcalorimetry, amphotericin B was the most active agent against Mucorales (MHIC 0"><entity charOffset="36-50" id="DDI-PubMed.22694788.s8.e0" text="amphotericin B" /></sentence><sentence text="06-0" /><sentence text="125 μg/mL) and Fusarium spp" /><sentence text=" (MHIC 1-4 μg/mL), whereas voriconazole was the most active agent against Scedosporium spp"><entity charOffset="27-39" id="DDI-PubMed.22694788.s11.e0" text="voriconazole" /></sentence><sentence text=" (MHIC 0" /><sentence text="25 to 8 μg/mL)" /><sentence text=" The percentage of agreement (within one 2-fold dilution) between the MHIC and MIC (or MEC) was 67%, 92%, 75%, and 83% for amphotericin B, voriconazole, posaconazole, and caspofungin, respectively"><entity charOffset="123-137" id="DDI-PubMed.22694788.s14.e0" text="amphotericin B" /><entity charOffset="139-151" id="DDI-PubMed.22694788.s14.e1" text="voriconazole" /><entity charOffset="153-165" id="DDI-PubMed.22694788.s14.e2" text="posaconazole" /><entity charOffset="171-182" id="DDI-PubMed.22694788.s14.e3" text="caspofungin" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e0" e2="DDI-PubMed.22694788.s14.e0" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e0" e2="DDI-PubMed.22694788.s14.e1" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e0" e2="DDI-PubMed.22694788.s14.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e0" e2="DDI-PubMed.22694788.s14.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e1" e2="DDI-PubMed.22694788.s14.e1" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e1" e2="DDI-PubMed.22694788.s14.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e1" e2="DDI-PubMed.22694788.s14.e3" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e2" e2="DDI-PubMed.22694788.s14.e2" /><pair ddi="false" e1="DDI-PubMed.22694788.s14.e2" e2="DDI-PubMed.22694788.s14.e3" /></sentence><sentence text=" Microcalorimetry provides additional information on timing of antifungal activity, enabling further investigation of drug-mold and drug-drug interaction, and optimization of antifungal treatment" /><sentence text="" /></document>